Amylotect – Calgary, Alberta
A presentation outlining Alzheimer’s disease (AD) and its mechanisms. AD is caused by a build-up of beta-amyloid proteins that initially form in the gut. Current diagnoses use neuroimaging and behavioral assessments, which are inefficient. We propose Amylotect: a tool that uses aptamers to detect beta-amyloid in stool samples. It is a cheap and effective way to diagnose Alzheimer’s, and has the capability of working before symptoms even start.
| Team Grade Level: | Collegiate |
| Team Experience Level: | |
| STEM Focus: | Synthetic Biology |
| UN Sustainability Focus: |
Prototype Pitch Video:
